Price T Rowe Associates Inc Bioventus Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,041 shares of BVS stock, worth $134,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,041Holding current value
$134,497% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding BVS
# of Institutions
107Shares Held
39.9MCall Options Held
138KPut Options Held
137K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$145 Million24.48% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$76.3 Million18.67% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.34MShares$59.6 Million2.05% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$26.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$18.5 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $689M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...